Active Surveillance for Small Kidney Tumors
The Delayed Intervention and Surveillance for Small Renal Masses (DISSRM) Registry
- Age
- 18 – 100
- Sex
- Any
- Study type
- Observational
- Participants needed
- 600 (estimated)
- Sponsor
- Abramson Cancer Center at Penn Medicine · Other
This trial is looking for adults with small kidney masses to see if watching the tumors is a safe option compared to immediate treatment. Participants will need to follow certain guidelines and timeframes during the study.
You may be able to join if
- I have a solid kidney mass that is 4 cm or smaller.
- I am at least 18 years old.
- I can read, understand, and sign an informed consent form.
- I am willing to follow the treatment plan and timeline.
You may not be able to join if
- I have been diagnosed with another cancer within the last two years.
- I have any signs that my kidney mass might have spread.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityRetrospective studies indicate that active surveillance for clinically localized, small renal masses (cT1a, \<=4cm) is safe. It is our hypothesis that active surveillance is safe and efficacious when compared prospectively to patients undergoing immediate intervention for their small renal mass.
Loading trial locations…